HHS OIG: Medicare Advantage, Medicaid, and physicians limit access to MOUD

Abstract

Patients with insurance coverage under Medicare — in particular, Medicare Advantage — or Medicaid are less likely to receive medications for opioid use disorder (MOUD) because providers are just unwilling to treat them, according to a report released last month by the federal Department of Health and Human Services (HHS) Office of Inspector General (OIG). The report repeatedly refers to “behavioral health,” so in this article, we do too.